GlassScriptPhysician profile
Alan L Rosenberg
NPI 1649246257
$808.81
in general payments reported to CMS, 2019-2025
11 companies · $82.63 in 2025
The $82.63 reported for 2025 was more than what a typical Anesthesiology provider received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $199 · 2020: $60.28 · 2021: $124 · 2022: $117 · 2023: $138 · 2024: $89.31 · 2025: $82.63.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $309.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $309.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $255.14 | 2019-2025 | Bridion |
| Cumberland Pharmaceuticals, INC. | $254.78 | 2019-2024 | Caldolor |
| Boston Scientific Corporation | $99.09 | 2024-2025 | Farapulse |
| Karl Storz Endoscopy-America | $81.25 | 2019-2020 | |
| Masimo Corporation | $21.04 | 2021 | |
| Baxter Healthcare | $20.09 | 2021 | |
| Medtronic, INC. | $18.84 | 2024 | Nellcor |
| Eagle Pharmaceuticals, INC. | $15.00 | 2023 | |
| Pacira Pharmaceuticals Incorporated | $14.93 | 2025 | Exparel |
| Vyaire Medical, INC. | $14.87 | 2023 | |
| Bard Peripheral Vascular, INC. | $13.78 | 2023 | Trek |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alan Rosenberg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.